SwELECT transfers 17.5 lakh shares in ESG Green Energy
SwELECT Energy Systems transferred 17.5 lakh shares in ESG Green Energy to Syrma SGS Technology on May 20, 2026. The shares, with a face value of ₹10 each, were off-market transferred. ESG Green Energy remains a subsidiary of SwELECT Energy Systems post-transfer.

*this image is generated using AI for illustrative purposes only.
swelect energy systems has transferred 17,50,000 equity shares in ESG Green Energy Private Limited. The off-market transfer was approved by the company's Investment Committee during its meeting held on May 20, 2026.
The transferred equity shares have a face value of ₹10 each. The shares were sold to Syrma SGS Technology Limited, identified as a proposed group captive consumer within the subsidiary company.
Transaction Details
The transfer involves the following key details regarding the transaction:
| Particulars | Details |
|---|---|
| Number of Shares Transferred | 17,50,000 |
| Face Value | ₹10 per share |
| Transferee | Syrma SGS Technology Limited |
| Date of Approval | May 20, 2026 |
Subsidiary Status
Despite the transfer of equity shares, the status of ESG Green Energy Private Limited remains unchanged. The company continues to be a subsidiary of SwELECT Energy Systems Limited. The compliance regarding this transfer has been submitted to the relevant stock exchanges for record.
Historical Stock Returns for SWELECT Energy Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.48% | +2.11% | -2.58% | -11.23% | +10.04% | +197.67% |
How will Syrma SGS Technology Limited's role as a group captive consumer impact ESG Green Energy's power generation capacity and revenue model going forward?
Could this equity transfer signal a broader strategy by SwELECT Energy Systems to onboard more industrial captive consumers into ESG Green Energy, and which sectors might be targeted next?
What financial and operational synergies might Syrma SGS Technology Limited unlock through its captive energy arrangement, and how could this affect its manufacturing cost structure?


































